Researchers use high-resolution imaging to observe HIV infection process in the cell nucleus

Scientists at EMBL Heidelberg and at the Zentrum für Infektiologie at Heidelberg University Hospital have succeeded for the first time in imaging HIV during transport into the nucleus of an infected cell.

The electron tomographic images show the protein envelope of the virus passing through one of the nuclear pores - the openings in the membrane around the nucleus that allow molecules in and out. The scientists found that the virus passes through the nuclear pore intact, only breaking apart inside the nucleus, where it releases its genetic information. This clarifies an important mechanism by which the virus's genetic material is integrated into the genome of the infected cell.

The human immunodeficiency virus type 1 (HIV-1) - which was the focus of this study - primarily infects certain cells of the immune system, and in this way massively weakens the body's own defence against diseases. The genetic material of the virus is securely packaged in a cone-shaped protein capsule known as the capsid, which is composed of individual hexagonal parts. Scientists knew how the capsid passes through the cell membrane into the interior of the cell during infection, but not how the virus's genetic material gets from the capsid into the cell nucleus, where it triggers the formation of new viruses.

This is where the work of the Heidelberg collaboration comes in. Using newly developed methods for 3D imaging of molecular complexes in virus-infected cells, the scientists succeeded in imaging the viral capsid directly during transport into the nucleus.

Until now, it was assumed that the capsid does not fit through the pores. However, the question of how the viral genome gets into the cell nucleus is essential for its reproduction. Our results therefore support the search for new targets for future therapeutic approaches."

Hans-Georg Kräusslich, Medical Director, Zentrum für Infektiologie

Although current treatment options can suppress multiplication of the virus in the body, a true cure that eliminates the virus is not yet possible.

Platforms for high-resolution imaging

To get a detailed look at the inner workings of infected immune cells in the laboratory, the scientists used high-resolution imaging techniques. With the help of the Electron Microscopy Core Facility at Heidelberg University and the Cryo-Electron Microscopy Service Platform at EMBL Heidelberg, they combined light and electron microscopy methods. They were able to reconstruct 3D images of the molecular structures from their data. This allowed them to visualise the composition and architecture of the viral complexes and their interaction with cellular structures in high resolution.

"The fruitful collaboration between our two institutions and the combination of specialised technology has helped to fit another piece of the HIV infection puzzle into the overall picture," says Martin Beck, a visiting group leader at EMBL and, since 2019, a Director and Scientific Member of the Max Planck Institute of Biophysics.

Source:
Journal reference:

Zila, V., et al. (2021) Cone-shaped HIV-1 capsids are transported through intact nuclear pores. Cell. doi.org/10.1016/j.cell.2021.01.025.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Georgetown University receives $27.5 million grant to combat HIV/AIDS in Haiti